Combining FVIIa and FX into a mixture which imparts a unique thrombin generation potential to hemophilic plasma: an in vitro assessment of FVIIa/FX mixture as an alternative bypassing agent
Authors:
- Teruhisa NakashimaTNTeruhisa Nakashima
- Soutaro GokudanSGSoutaro Gokudan
- Hiroki MiyazakiHMHiroki Miyazaki
- Manami TsujiMTManami Tsuji
- Takako Hanada-DatekiTHTakako Hanada-Dateki
- Tatsuya ArakiTATatsuya Araki
- Kazuhiko TomokiyoKTKazuhiko Tomokiyo
- Takayoshi HamamotoTHTakayoshi Hamamoto
- Yoichi OgataYOYoichi Ogata
- 1 May 2010
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 125 (5) , 457-463
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasmaHaemophilia, 2008
- Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia ABlood, 2008
- Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleedingHaemophilia, 2008
- Inhibitor development in haemophilia B: an orphan disease in need of attentionBritish Journal of Haematology, 2007
- Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experienceHaemophilia, 2007
- A Variant of Recombinant Factor VIIa With Enhanced Procoagulant and Antifibrinolytic Activities in an In Vitro Model of HemophiliaArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) StudyBlood, 2006
- The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII–tissue factor complexJournal of Thrombosis and Haemostasis, 2005
- Role of the N-terminal Epidermal Growth Factor-like Domain of Factor X/XaJournal of Biological Chemistry, 2004
- Monitoring the bioavailability of FEIBA with a thrombin generation assayJournal of Thrombosis and Haemostasis, 2003